Covered recipient · General Payments record
ROSE MARY FAIR COVELY
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$1,354.97
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $280.59 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $185.18 | 13 |
| Novo Nordisk AS | $54.60 | 3 |
| DEXCOM, INC. | $24.99 | 1 |
| Lilly USA, LLC | $15.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.28 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918749 | CMS |
| Abbott Laboratories | $12.82 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918751 | CMS |
| Abbott Laboratories | $23.56 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918753 | CMS |
| Abbott Laboratories | $18.86 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918755 | CMS |
| Abbott Laboratories | $8.08 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918757 | CMS |
| Abbott Laboratories | $5.21 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918773 | CMS |
| Abbott Laboratories | $20.52 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918771 | CMS |
| Abbott Laboratories | $3.20 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918759 | CMS |
| Abbott Laboratories | $9.67 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918761 | CMS |
| Abbott Laboratories | $17.11 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918763 | CMS |
| Abbott Laboratories | $17.66 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918765 | CMS |
| Abbott Laboratories | $17.66 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918767 | CMS |
| Abbott Laboratories | $13.55 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124918769 | CMS |
| Dexcom, Inc. | $24.99 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153332663 | CMS |
| Lilly USA, LLC | $15.82 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135379422 | CMS |
| Novo Nordisk Inc | $18.90 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096846789 | CMS |
| Novo Nordisk Inc | $17.07 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097461947 | CMS |
| Novo Nordisk Inc | $18.63 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096939507 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.